stock-detail (TGTX)

Oncology Corporate Profile

Company Description

This company does not have any commercial products

This company does not have any pipeline products

Recent News Headlines

4/23/2017 12:19 pm

4/23/2017 12:19 pm

4/23/2017 12:19 pm

4/23/2017 12:19 pm

4/23/2017 12:19 pm

4/21/2017 12:19 pm

4/21/2017 12:19 pm

4/21/2017 12:19 pm

4/21/2017 12:19 pm

4/20/2017 12:19 pm

4/20/2017 12:19 pm

4/20/2017 12:19 pm

4/20/2017 12:19 pm

4/20/2017 12:19 pm

4/18/2017 06:19 am

4/7/2017 06:17 am

TG Therapeutics, Inc. Announces Preclinical Data Presentation at the 2017 American Association for Cancer Research (AACR) Annual Meeting

3/20/2017 11:03 am

[GlobeNewswire] - NEW YORK, March 20, 2017-- TG Therapeutics, Inc., today announced that preclinical data for the Company’ s anti-PD-L1 monoclonal antibody, has been selected for presentation at the upcoming American Association ...

TG Therapeutics, Inc. to Present at the 27th Annual Oppenheimer Healthcare Conference

3/17/2017 11:03 am

[GlobeNewswire] - NEW YORK, March 17, 2017-- TG Therapeutics, Inc. today announced that Michael S. Weiss, the Company’ s Executive Chairman and Chief Executive Officer, will present at the 27 th Annual Oppenheimer Healthcare ...

TG Therapeutics and ImmunoGen are Models of Institutional Investor Attention

3/16/2017 01:03 pm

[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 16, 2017 / One question many investors have is how much emphasis should be put on insider trading reports and institutional investor activity. The recent activity of TG ...